Dr Wainberg and Dr Gerson talk about the efficacy limitations of cytotoxic chemotherapy on some cells for a variety of reasons.
PMO Interview with the Innovator Series: Volume 11
Dr Gerson offers insights into the various aspect’s of stem cells, including the ability to replicate, rest, and spread to different locations.
Dr Gerson discusses the process in which genetic changes cause tumors to grow.
Dr Wainberg and Dr Gerson talk about the two different cell types that lead to metastasis and the process of stem cell growth.
Dr Wainberg and Dr Gerson discuss features of stem cells and how in understanding their features they can be targeted for therapeutics.
Dr Wainberg and Dr Gerson discuss how biomarkers may help identify cancer stem cells.
Dr Wainberg and Dr Gerson review why providers are using combination therapies and the eventual goal of investigators to hit specific targeted cells.
Dr Wainberg expands upon what makes these types of cells unique.
Dr Wainberg and Dr Gerson talk about blocking cancer stem cell pathways and how randomized trials using therapies aimed at these pathways.
Dr Wainberg and Dr Gerson identify some of the challenges of preclinical models versus clinical trials.